CXC趋化因子12（CXCL12）中性配体的前药可预防体内哮喘模型中的炎症反应。
Prodrugs of a CXC Chemokine-12 (CXCL12) Neutraligand Prevent Inflammatory Reactions in an Asthma Model in Vivo.
作者信息
Gasparik Vincent, Daubeuf François, Hachet-Haas Muriel, Rohmer François, Gizzi Patrick, Haiech Jacques, Galzi Jean-Luc, Hibert Marcel, Bonnet Dominique, Frossard Nelly
机构信息
Laboratoire d'Innovation Thérapeutique, UMR 7200 CNRS/Université de Strasbourg , Faculté de Pharmacie, 74 route du Rhin, 67401 Illkirch, France.
Biotechnologie et signalisation cellulaire, UMR 7242 CNRS/Université de Strasbourg , ESBS, Bld Sébastien Brant, 67412 Illkirch, France.
出版信息
ACS Med Chem Lett. 2011 Dec 9;3(1):10-4. doi: 10.1021/ml200017d. eCollection 2012 Jan 12.
Abstract
Chalcone 4 (compound 1) is a small molecule that neutralizes the CXC chemokine CXCL12 and prevents it from acting on the CXCR4 and CXCR7 receptors. To overcome its poor solubility in aqueous buffers, we designed highly soluble analogues of compound 1, phosphate, l-seryl, and sulfate, all inactive by themselves on CXCL12 but when cleaved in vivo into 1, highly active locally at a low dose in a mouse airway hypereosinophilia model.
摘要
查耳酮4（化合物1）是一种小分子，它能中和CXC趋化因子CXCL12，并阻止其作用于CXCR4和CXCR7受体。为克服其在水性缓冲液中溶解度差的问题，我们设计了化合物1的高溶解性类似物，即磷酸盐、L-丝氨酸盐和硫酸盐，它们自身对CXCL12均无活性，但在体内裂解成1后，在小鼠气道嗜酸性粒细胞增多模型中以低剂量局部具有高活性。
相似文献
1
Prodrugs of a CXC Chemokine-12 (CXCL12) Neutraligand Prevent Inflammatory Reactions in an Asthma Model in Vivo.CXC趋化因子12（CXCL12）中性配体的前药可预防体内哮喘模型中的炎症反应。
ACS Med Chem Lett. 2011 Dec 9;3(1):10-4. doi: 10.1021/ml200017d. eCollection 2012 Jan 12.
2
Discovery of a Locally and Orally Active CXCL12 Neutraligand (LIT-927) with Anti-inflammatory Effect in a Murine Model of Allergic Airway Hypereosinophilia.发现一种局部和口服活性的 CXCL12 中和配体（LIT-927），在变应性气道嗜酸性粒细胞增多症的小鼠模型中具有抗炎作用。
J Med Chem. 2018 Sep 13;61(17):7671-7686. doi: 10.1021/acs.jmedchem.8b00657. Epub 2018 Aug 28.
3
Decreased Migration of Dendritic Cells into the Jugular-Nodose Ganglia by the CXCL12 Neutraligand Chalcone 4 in Ovalbumin-Sensitized Asthmatic Mice.卵清蛋白致敏哮喘小鼠中，CXCL12 中性配体查耳酮 4 减少树突状细胞向颈静脉-结状神经节的迁移。
Neuroimmunomodulation. 2017;24(6):331-340. doi: 10.1159/000487140. Epub 2018 Apr 20.
4
An antedrug of the CXCL12 neutraligand blocks experimental allergic asthma without systemic effect in mice.一种 CXCL12 中性配体的抗药物在小鼠中阻断实验性变应性哮喘而无全身作用。
J Biol Chem. 2013 Apr 26;288(17):11865-76. doi: 10.1074/jbc.M112.449348. Epub 2013 Feb 28.
5
CXCL12-CXCR4/CXCR7 Axis in Colorectal Cancer: Therapeutic Target in Preclinical and Clinical Studies.CXCL12-CXCR4/CXCR7 轴在结直肠癌中的作用：临床前和临床研究中的治疗靶点。
Int J Mol Sci. 2021 Jul 9;22(14):7371. doi: 10.3390/ijms22147371.
6
Biological/pathological functions of the CXCL12/CXCR4/CXCR7 axes in the pathogenesis of bladder cancer.CXCL12/CXCR4/CXCR7 轴在膀胱癌发病机制中的生物学/病理学功能。
Int J Clin Oncol. 2017 Dec;22(6):991-1000. doi: 10.1007/s10147-017-1187-x. Epub 2017 Oct 11.
7
[Role of CXCL12-CXCR4/CXCR7 signal axis in liver regeneration and liver fibrosis].[CXCL12-CXCR4/CXCR7信号轴在肝再生和肝纤维化中的作用]
Zhonghua Gan Zang Bing Za Zhi. 2021 Sep 20;29(9):900-903. doi: 10.3760/cma.j.cn501113-20200721-00403.
8
CXC chemokine receptor 7 (CXCR7) regulates CXCR4 protein expression and capillary tuft development in mouse kidney.CXC 趋化因子受体 7（CXCR7）调节小鼠肾脏中 CXCR4 蛋白的表达和毛细血管丛的发育。
PLoS One. 2012;7(8):e42814. doi: 10.1371/journal.pone.0042814. Epub 2012 Aug 6.
9
Small neutralizing molecules to inhibit actions of the chemokine CXCL12.抑制趋化因子CXCL12作用的小分子中和剂。
J Biol Chem. 2008 Aug 22;283(34):23189-99. doi: 10.1074/jbc.M803947200. Epub 2008 Jun 13.
10
Scavenging of CXCL12 by CXCR7 promotes tumor growth and metastasis of CXCR4-positive breast cancer cells.趋化因子 CXCL12 被 CXCR7 清除可促进 CXCR4 阳性乳腺癌细胞的肿瘤生长和转移。
Oncogene. 2012 Nov 8;31(45):4750-8. doi: 10.1038/onc.2011.633. Epub 2012 Jan 23.
引用本文的文献
1
Design, Synthesis and Biological Evaluation of Prodrugs of 666-15 as Inhibitors of CREB-Mediated Gene Transcription.666-15前药作为CREB介导的基因转录抑制剂的设计、合成及生物学评价
ACS Med Chem Lett. 2022 Feb 17;13(3):388-395. doi: 10.1021/acsmedchemlett.1c00499. eCollection 2022 Mar 10.
2
A Selective Neutraligand for CXCL12/SDF-1α With Beneficial Regulatory Functions in MRL/Lpr Lupus Prone Mice.一种对CXCL12/SDF-1α具有选择性的中性配体，在MRL/Lpr狼疮易感小鼠中具有有益的调节功能。
Front Pharmacol. 2021 Oct 21;12:752194. doi: 10.3389/fphar.2021.752194. eCollection 2021.
3
An optimized derivative of an endogenous CXCR4 antagonist prevents atopic dermatitis and airway inflammation.一种内源性CXCR4拮抗剂的优化衍生物可预防特应性皮炎和气道炎症。
Acta Pharm Sin B. 2021 Sep;11(9):2694-2708. doi: 10.1016/j.apsb.2020.12.005. Epub 2020 Dec 13.
4
Identification of Interleukin-8-Reducing Lead Compounds Based on SAR Studies on Dihydrochalcone-Related Compounds in Human Gingival Fibroblasts (HGF-1 cells) In Vitro.基于二氢查尔酮类化合物在人牙龈成纤维细胞（HGF-1 细胞）体外对白细胞介素-8 降低作用的 SAR 研究鉴定出的潜在 lead compounds。
Molecules. 2020 Mar 18;25(6):1382. doi: 10.3390/molecules25061382.
5
Pharmacological tools to mobilise mesenchymal stromal cells into the blood promote bone formation after surgery.促使间充质基质细胞进入血液的药理学工具可促进术后骨形成。
NPJ Regen Med. 2020 Feb 21;5:3. doi: 10.1038/s41536-020-0088-1. eCollection 2020.
6
Two distinct CXCR4 antagonists mobilize progenitor cells in mice by different mechanisms.两种不同的CXCR4拮抗剂通过不同机制动员小鼠体内的祖细胞。
Blood Adv. 2017 Oct 10;1(22):1934-1943. doi: 10.1182/bloodadvances.2017006064.
7
Chalcone Derivatives: Promising Starting Points for Drug Design.查尔酮衍生物：药物设计的理想起始点
Molecules. 2017 Jul 25;22(8):1210. doi: 10.3390/molecules22081210.
8
The Prodrug Approach: A Successful Tool for Improving Drug Solubility.前药方法：提高药物溶解度的成功工具。
Molecules. 2015 Dec 29;21(1):42. doi: 10.3390/molecules21010042.
9
A strategy to discover decoy chemokine ligands with an anti-inflammatory activity.一种发现具有抗炎活性的诱饵趋化因子配体的策略。
Sci Rep. 2015 Oct 7;5:14746. doi: 10.1038/srep14746.
10
An antedrug of the CXCL12 neutraligand blocks experimental allergic asthma without systemic effect in mice.一种 CXCL12 中性配体的抗药物在小鼠中阻断实验性变应性哮喘而无全身作用。
J Biol Chem. 2013 Apr 26;288(17):11865-76. doi: 10.1074/jbc.M112.449348. Epub 2013 Feb 28.
本文引用的文献
1
Prodrugs--from serendipity to rational design.前药——从偶然发现到合理设计。
Pharmacol Rev. 2011 Sep;63(3):750-71. doi: 10.1124/pr.110.003459. Epub 2011 Jul 7.
2
Chromatographic Hydrophobicity Index by Fast-Gradient RP-HPLC: A High-Throughput Alternative to log P/log D.快速梯度反相高效液相色谱法测定的色谱疏水性指数：log P/log D的高通量替代方法
Anal Chem. 1997 Jun 1;69(11):2022-9. doi: 10.1021/ac961242d.
3
Targeting SDF-1/CXCL12 with a ligand that prevents activation of CXCR4 through structure-based drug design.通过基于结构的药物设计靶向 SDF-1/CXCL12 与一种配体，该配体可阻止 CXCR4 的激活。
J Am Chem Soc. 2010 Jun 2;132(21):7242-3. doi: 10.1021/ja1002263.
4
Neutralizing endogenous chemokines with small molecules. Principles and potential therapeutic applications.用小分子中和内源性趋化因子。原理和潜在的治疗应用。
Pharmacol Ther. 2010 Apr;126(1):39-55. doi: 10.1016/j.pharmthera.2009.12.003. Epub 2010 Feb 1.
5
French/European academic compound library initiative.法国/欧洲学术化合物文库计划
Drug Discov Today. 2009 Aug;14(15-16):723-5. doi: 10.1016/j.drudis.2009.05.012. Epub 2009 Jun 9.
6
Small neutralizing molecules to inhibit actions of the chemokine CXCL12.抑制趋化因子CXCL12作用的小分子中和剂。
J Biol Chem. 2008 Aug 22;283(34):23189-99. doi: 10.1074/jbc.M803947200. Epub 2008 Jun 13.
7
Development of prodrug 4-chloro-3-(5-methyl-3-{[4-(2-pyrrolidin-1-ylethoxy)phenyl]amino}-1,2,4-benzotriazin-7-yl)phenyl benzoate (TG100801): a topically administered therapeutic candidate in clinical trials for the treatment of age-related macular degeneration.前药4-氯-3-(5-甲基-3-{[4-(2-吡咯烷-1-基乙氧基)苯基]氨基}-1,2,4-苯并三嗪-7-基)苯甲酸苯酯（TG100801）的研发：一种正在进行治疗年龄相关性黄斑变性临床试验的局部给药治疗候选药物。
J Med Chem. 2008 Mar 27;51(6):1546-59. doi: 10.1021/jm7011276. Epub 2008 Feb 27.
8
Prodrugs: design and clinical applications.前体药物：设计与临床应用
Nat Rev Drug Discov. 2008 Mar;7(3):255-70. doi: 10.1038/nrd2468.
9
AMD3465, a novel CXCR4 receptor antagonist, abrogates schistosomal antigen-elicited (type-2) pulmonary granuloma formation.AMD3465，一种新型的CXCR4受体拮抗剂，可消除血吸虫抗原引发的（2型）肺肉芽肿形成。
Am J Pathol. 2006 Aug;169(2):424-32. doi: 10.2353/ajpath.2006.051234.
10
Synthesis of some pyrazole derivatives and preliminary investigation of their affinity binding to P-glycoprotein.一些吡唑衍生物的合成及其与P-糖蛋白亲和力结合的初步研究。
Bioorg Med Chem Lett. 2005 Oct 15;15(20):4632-5. doi: 10.1016/j.bmcl.2005.05.067.
Zotero 插件